Alzheimer Disease Biomarker Test Results

Name: How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
Uploaded: 2025-10-10T16:00:00+00:00
Description: Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the res

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Neurology in Motion
Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD
Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
Neurology in Motion
Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD
Factors Influencing the Selection of CSF Tests for Alzheimer Disease
Factors Influencing the Selection of CSF Tests for Alzheimer Disease
Neurology in Motion
Factors Influencing the Selection of CSF Tests for Alzheimer Disease
Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD
Biomarker Testing Modalities for Alzheimer Disease

Biomarker Testing Modalities for Alzheimer Disease

Neurology in Motion
Biomarker Testing Modalities for Alzheimer Disease

Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD